In what may be the first of its kind research, a heart surgeon says that he might have saved the life of a baby using stem cells from the placenta to repair a heart condition. The procedure took place in the United Kingdom where a now two-year-old boy Finley was treated using the “allogenic” cells, grown by scientists at the Royal Free Hospital in London.&nbsp;

The heart surgeon and researcher, Professor Massimo Caputo from the Bristol Heart Institute, said that he “probably saved the life” of the baby by using stem cells “scaffolding” to correct the boy’s heart defect, reported BBC. In an interview with the British Heart Foundation, Caputo said that one of his research priorities was using this method to avoid repeated operations for babies and children suffering from congenital heart disease.&nbsp;

ALSO READ |&nbsp;<a href="https://www.wionews.com/science/ai-predicts-risk-of-heart-disease-with-simple-eye-test-in-less-than-a-minute-says-study-523154">AI predicts risk of heart disease with simple eye test, in less than a minute, says study</a>

According to the Centers for Disease Control and Prevention, Congenital heart defects (CHDs) are the most common type of birth defect. Present since birth CHD affects the structure of a child’s heart and its functions including the blood flow from the heart to the rest of the body. It ranges from “mild (such as a small hole in the heart) to severe (such as missing or poorly formed parts of the heart),” said the CDC. &nbsp;

“Every time you do heart surgery on the same person it gets more risky. Even though we are now getting good outcomes in terms of survival, there is still the risk of complications – infections, damage to the brain or lungs – that can affect quality of life long term. And there is the psychological toll of repeated surgery, too,” said the heart surgeon explaining the long-term risks of surgeries.&nbsp;

According to the Bristol Royal Hospital for Children website, Finley was four days old when he had his first heart surgery after the hospital found that he had the heart condition, “which meant that the two main blood vessels leaving his heart were in the wrong order. The left side of Finley’s heart was also missing coronary arteries which supply blood, oxygen, and nutrients to the heart,” said his mother Melissa.&nbsp;

ALSO WATCH |&nbsp;<a href="https://www.wionews.com/videos/doctors-may-have-saved-a-babys-heart-using-umbilical-stem-cells-544783">Doctors may have saved a baby's heart using umbilical stem cells</a>

Subsequently, a 12-hour of surgery was conducted but the boy still needed a heart and lung bypass machine to aid his deteriorating heart function and was placed in an ICU for weeks, she added. Therefore, when all conventional means failed Professor Caputo suggested the stem cell method, in line with which had injected millions of “allogenic” cells directly into Finley’s heart hoping it would help blood vessels grow.&nbsp;

“We are trying to create living tissue, whether it’s a valve or a blood vessel or a patch, that will grow with the child, and that does not deteriorate. I think that would massively change their quality of life,” he previously said in an interview with BHF.&nbsp; 
 
ALSO READ |&nbsp;<a href="https://www.wionews.com/trending/world-heart-day-2022-theme-history-and-everything-you-need-to-know-520681">World Heart Day 2022: Theme, history, and everything you need to know&nbsp;</a> 
 
While allogenic stem transplant uses cells collected from a donor, they are matched with the patient in order to suppress the disease and restore the patient's immune system as well as have the ability to grow into tissue. Subsequently, it was not rejected in Finley’s case and worked to regenerate the damaged heart muscle.&nbsp;

On the other hand, artificial tissue is typically used to repair cardiac abnormalities in babies but it does not grow with the heart and as the child grows up, they would require additional operations.&nbsp; 
&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

In what may be the first of its kind research, a heart surgeon says that he might have saved the life of a baby using stem cells from the placenta to repair a heart condition.

In what may be the first of its kind research, a heart surgeon says that he might have saved the life of a baby using stem cells from the placenta to repair a heart condition. The procedure took place in the United Kingdom where a now two-year-old boy Finley was treated using the “allogenic” cells, grown by scientists at the Royal Free Hospital in London. The heart surgeon and researcher, Professor Massimo Caputo from the Bristol Heart Institute, said that he “probably saved the life” of the baby by using stem cells “scaffolding” to correct the boy’s heart defect, reported BBC. In an interview with the British Heart Foundation, Caputo said that one of his research priorities was using this method to avoid repeated operations for babies and children suffering from congenital heart disease. ALSO READ | AI predicts risk of heart disease with simple eye test, in less than a minute, says study According to the Centers for Disease Control and Prevention, Congenital heart defects (CHDs) are the most common type of birth defect. Present since birth CHD affects the structure of a child’s heart and its functions including the blood flow from the heart to the rest of the body. It ranges from “mild (such as a small hole in the heart) to severe (such as missing or poorly formed parts of the heart),” said the CDC. “Every time you do heart surgery on the same person it gets more risky. Even though we are now getting good outcomes in terms of survival, there is still the risk of complications – infections, damage to the brain or lungs – that can affect quality of life long term. And there is the psychological toll of repeated surgery, too,” said the heart surgeon explaining the long-term risks of surgeries. According to the Bristol Royal Hospital for Children website, Finley was four days old when he had his first heart surgery after the hospital found that he had the heart condition, “which meant that the two main blood vessels leaving his heart were in the wrong order. The left side of Finley’s heart was also missing coronary arteries which supply blood, oxygen, and nutrients to the heart,” said his mother Melissa. ALSO WATCH | Doctors may have saved a baby's heart using umbilical stem cells Subsequently, a 12-hour of surgery was conducted but the boy still needed a heart and lung bypass machine to aid his deteriorating heart function and was placed in an ICU for weeks, she added. Therefore, when all conventional means failed Professor Caputo suggested the stem cell method, in line with which had injected millions of “allogenic” cells directly into Finley’s heart hoping it would help blood vessels grow. “We are trying to create living tissue, whether it’s a valve or a blood vessel or a patch, that will grow with the child, and that does not deteriorate. I think that would massively change their quality of life,” he previously said in an interview with BHF. ALSO READ | World Heart Day 2022: Theme, history, and everything you need to know While allogenic stem transplant uses cells collected from a donor, they are matched with the patient in order to suppress the disease and restore the patient's immune system as well as have the ability to grow into tissue. Subsequently, it was not rejected in Finley’s case and worked to regenerate the damaged heart muscle. On the other hand, artificial tissue is typically used to repair cardiac abnormalities in babies but it does not grow with the heart and as the child grows up, they would require additional operations. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

In a first, doctor may have saved a baby’s life by repairing heart using umbilical stem cells

Heart surgeon Massimo Caputo from the Briston Heart Institute used what is called stem cell scaffolding to correct a baby's heart defect. With this advanced technology, he hopes that children who are born with congenital cardiac disease won't need as many operations. Watch this to know more.

Doctors may have saved a baby's heart using umbilical stem cells

According to a new research, stem cells can be regrown in damaged umbilical cord.

Research by Notre Dame University revealed a "new strategy" that can restore the damaged stem cells and enable it to grow new tissues again.

<a href="https://www.wionews.com/world/stem-cell-transplant-cures-woman-of-hiv-researchers-report-453666">Also Read:&nbsp;Stem cell transplant cures HIV+&nbsp;woman, third person to be cured of infection</a>

The new approach is based on specially engineered "nanoparticles" which can store medicine and deliver it just to the stem cells by attaching directly to the stem cells’ surface. It is just 150 nanometres in diameter, the study said. The particles release the medicine slowly "making it highly effective even at very low doses".&nbsp;

Watch:&nbsp;Scientists create the world's first 'artificial' embryos

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/israeli-scientists-create-the-worlds-first-artificial-embryos-synthetic-mouse-embryos-made-from-stem-cells-504220/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

Donny Hanjaya-Putra who conducted the study said: "it is smart and effective" while adding that, "Each stem cell is like a soldier. It knows where to go and what to do. But the ‘soldiers’ we are working with are injured and weak. By providing them with this nanoparticle ‘backpack,’ we are giving them what they need to work effectively again.”

The "backpacks" enabled the damaged stem cells to form new blood vessels during the experiment with mice. However, it could take many years before the new technique can become part of healthcare, scientists say.

The researchers said&nbsp;the new approach will help to restore cells damaged by pregnancy complications, so instead of discarding the stem cells, clinicians will be able to "rejuvenate" them and it will also help in "child’s developmental outcomes".

(With inputs from Agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

According to a new research, stem cells can be regrown in damaged umbilical cord. Research by Notre Dame University revealed a "new strategy" that can restore the damaged stem cells and enable it to grow new tissues again.

According to a new research, stem cells can be regrown in damaged umbilical cord. Research by Notre Dame University revealed a "new strategy" that can restore the damaged stem cells and enable it to grow new tissues again. Also Read: Stem cell transplant cures HIV+ woman, third person to be cured of infection The new approach is based on specially engineered "nanoparticles" which can store medicine and deliver it just to the stem cells by attaching directly to the stem cells’ surface. It is just 150 nanometres in diameter, the study said. The particles release the medicine slowly "making it highly effective even at very low doses". Watch: Scientists create the world's first 'artificial' embryos Donny Hanjaya-Putra who conducted the study said: "it is smart and effective" while adding that, "Each stem cell is like a soldier. It knows where to go and what to do. But the ‘soldiers’ we are working with are injured and weak. By providing them with this nanoparticle ‘backpack,’ we are giving them what they need to work effectively again.” The "backpacks" enabled the damaged stem cells to form new blood vessels during the experiment with mice. However, it could take many years before the new technique can become part of healthcare, scientists say. The researchers said the new approach will help to restore cells damaged by pregnancy complications, so instead of discarding the stem cells, clinicians will be able to "rejuvenate" them and it will also help in "child’s developmental outcomes". (With inputs from Agencies) WATCH WION LIVE HERE

Saving the umbilical cord: Researchers show how damaged stem cells can be restored